Mianserinum

URI: https://gptkb.org/entity/Mianserinum
GPTKB entity
Statements (36)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
antidepressant
gptkbp:approvedBy gptkb:Australia
gptkb:Europe
gptkb:New_Zealand
gptkbp:ATCCode N06AX03
gptkbp:CASNumber 24219-97-4
gptkbp:compatibleWith gptkb:United_States
gptkbp:contraindication mania
hypersensitivity to mianserin
gptkbp:developedBy gptkb:Organon
gptkbp:discoveredBy 1970s
gptkbp:drugClass antidepressant
gptkbp:eliminationHalfLife 21-61 hours
gptkbp:excretion urine
feces
gptkbp:hasMolecularFormula C18H20N2
https://www.w3.org/2000/01/rdf-schema#label Mianserinum
gptkbp:IUPACName 1,2,3,4,10,14b-hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepine
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:Tolvon
gptkbp:mechanismOfAction norepinephrine reuptake inhibitor
serotonin receptor antagonist
gptkbp:metabolism liver
gptkbp:molecularWeight 264.37 g/mol
gptkbp:relatedTo mirtazapine
gptkbp:routeOfAdministration oral
gptkbp:sideEffect constipation
dizziness
weight gain
drowsiness
dry mouth
gptkbp:synonym mianserin
gptkbp:usedFor treatment of depression
gptkbp:bfsParent gptkb:Mianserin
gptkbp:bfsLayer 7